MDXG CIK: 1376339

MiMedx Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.98
FY22:
−17.9
FY23:
26.8
FY24:
66.2
FY25:
74.0
Change from FY21 to FY25
millions USD
FY21:
−3.40
FY22:
−2.66
FY23:
−2.16
FY24:
−9.58
FY25:
−6.89
Change from FY21 to FY25
millions USD
FY21:
−3.35
FY22:
−0.58
FY23:
−8.57
FY24:
−34.2
FY25:
−5.41
millions USD
FY21:
−8.73
FY22:
−21.1
FY23:
16.1
FY24:
22.4
FY25:
61.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.20
FY22:
−19.4
FY23:
24.8
FY24:
64.5
FY25:
73.0

All amounts in millions USD Data source:SEC EDGAR